Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB

R Ravi1, G C Bedi, L W Engstrom

  • 1Johns Hopkins Oncology Center, The Johns Hopkins University School of Medicine, Bunting-Blaustein Cancer Research Building, 1650 Orleans Street, Baltimore, Maryland 21231, USA.

Nature Cell Biology
|April 3, 2001
PubMed

Insights

The transcription factor NF-kappaB, specifically its c-Rel subunit, regulates expression of death receptors TRAIL-R1 and TRAIL-R2. NF-kappaB also influences apoptosis by controlling Bcl-xL, impacting cell sensitivity to TRAIL-induced cell death.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Immunology

Background:

  • Tumour-necrosis factor-related apoptosis ligand (TRAIL) induces apoptosis via death receptors TRAIL-R1 (DR4) and TRAIL-R2 (DR5).
  • The transcription factor NF-kappaB plays a complex role in cellular responses, including apoptosis.
  • Understanding NF-kappaB's regulation of TRAIL signaling is crucial for cancer therapy and immune responses.

Purpose of the Study:

  • To investigate the role of the c-Rel subunit of NF-kappaB in regulating TRAIL death receptor expression.
  • To determine how NF-kappaB activation influences the expression of the apoptosis inhibitor Bcl-xL.
  • To elucidate the dual functions of NF-kappaB in mediating or inhibiting apoptosis.

Main Methods:

  • Utilizing transdominant mutants of IkappaBalpha and transactivation-deficient c-Rel mutants to assess NF-kappaB's effect on death receptor expression.
  • Employing cytokine-mediated activation to study the impact of RelA on Bcl-xL expression.
  • Inhibiting NF-kappaB activation via the IkappaB kinase complex to evaluate its effect on Bcl-xL and TRAIL sensitivity.

Main Results:

  • The c-Rel subunit of NF-kappaB was found to induce the expression of TRAIL-R1 and TRAIL-R2.
  • Conversely, inhibition of NF-kappaB signaling led to reduced expression of these death receptors.
  • Cytokine-mediated NF-kappaB activation (RelA) increased Bcl-xL expression, conferring resistance to TRAIL, while NF-kappaB inhibition sensitized cells to TRAIL.

Conclusions:

  • NF-kappaB, through its subunits c-Rel and RelA, directly regulates the expression of TRAIL death receptors and the apoptosis inhibitor Bcl-xL.
  • These regulatory functions explain the observed dual role of NF-kappaB as both a promoter and inhibitor of apoptosis.
  • Targeting NF-kappaB signaling could modulate TRAIL-induced apoptosis in cancer treatment and immune regulation.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...